Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems.
Ken Y ChanMin J JangBryan B YooAlon GreenbaumNamita RaviWei-Li WuLuis Sánchez-GuardadoCarlos LoisSarkis K MazmanianBenjamin E DevermanViviana GradinaruPublished in: Nature neuroscience (2017)
Adeno-associated viruses (AAVs) are commonly used for in vivo gene transfer. Nevertheless, AAVs that provide efficient transduction across specific organs or cell populations are needed. Here, we describe AAV-PHP.eB and AAV-PHP.S, capsids that efficiently transduce the central and peripheral nervous systems, respectively. In the adult mouse, intravenous administration of 1 × 1011 vector genomes (vg) of AAV-PHP.eB transduced 69% of cortical and 55% of striatal neurons, while 1 × 1012 vg of AAV-PHP.S transduced 82% of dorsal root ganglion neurons, as well as cardiac and enteric neurons. The efficiency of these vectors facilitates robust cotransduction and stochastic, multicolor labeling for individual cell morphology studies. To support such efforts, we provide methods for labeling a tunable fraction of cells without compromising color diversity. Furthermore, when used with cell-type-specific promoters and enhancers, these AAVs enable efficient and targetable genetic modification of cells throughout the nervous system of transgenic and non-transgenic animals.
Keyphrases
- gene therapy
- spinal cord
- induced apoptosis
- cell cycle arrest
- single cell
- neuropathic pain
- genome wide
- copy number
- signaling pathway
- stem cells
- spinal cord injury
- dna methylation
- cell death
- high dose
- gene expression
- mesenchymal stem cells
- heart failure
- functional connectivity
- oxidative stress
- low dose
- parkinson disease
- quality improvement
- atrial fibrillation
- bone marrow
- genetic diversity
- energy transfer
- flow cytometry
- chemotherapy induced
- quantum dots
- genome wide identification